MargaretA.TemperoMD

Professor of Medicine, UCSF

Join Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1600 Divisadero St
San Francisco, CA 94143
Phone+1 415-353-9888

Fax+1 415-353-7150

Dr. Margaret Tempero, MD is an oncologist in San Francisco, California. She is currently licensed to practice medicine in California and Iowa. She is a Professor of Medicine at UCSF.

PubMed

Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancreatic Cancer.
Phoebe N Miller, Fernanda Romero-Hernandez, Lucia Calthorpe, Jaeyun Jane Wang, Sunhee S Kim
Annals of Surgical Oncology. 2024-09-01
ASO Visual Abstract: Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancreatic Cancer.
Phoebe N Miller, Fernanda Romero-Hernandez, Lucia Calthorpe, Jaeyun Jane Wang, Sunhee S Kim
Annals of Surgical Oncology. 2024-07-27
23 citations
Ampullary Adenocarcinoma, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.
E Gabriela Chiorean, Marco Del Chiaro, Margaret A Tempero, Mokenge P Malafa, Al B Benson
Journal of the National Comprehensive Cancer Network. 2023-07-01

JCO Article Insights: Use of Independently-Assessed vs Investigator-Assessed DFS in the APACT TrialMay 15th, 2023
New Advisory Board Chair Has Been Part of PanCAN Since the BeginningJuly 7th, 2021
The Pancreatic Cancer Action Network (PanCAN) Welcomes Two New Board Members and Scientific and Medical Advisory Board ChairJuly 6th, 2021
Join now to see all